About this trial
The primary objective is to assess if an AI-generated plain language summary of an inpatient progress note can improve caregiver understanding of their child's hospitalization by measuring differences in Hospital Course Comprehension scores, based on their responses to a survey regarding their child's hospital course.
Secondary objectives include exploring the caregiver's perspective on the use of AI in clinical care, as well as 7-day and 30-day readmission rates, 7-day and 30-day emergency department (ED) re-utilization rates, length of stay, and environmental impact measures.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Caregivers of patients older than age 10 years
Caregivers of patients not admitted to the Hospital Medicine service
Caregivers of admitted patients whose preferred language is non-English
Patients whose care summaries are deemed inaccurate by their attending physician and not eligible for sharing with their caregiver.
Trial design
Parallel
Treatments tested in this trial
AI Care Summary
Other interventionWritten AI-generated plain-language summary of the patient's hospital course, reviewed and approved by the attending physician and provided to the caregiver during the hospitalization.
Treatment groups
Trial outcomes
Primary outcomes
Hospital Course Comprehension Score
Percentage of caregiver survey responses that align with information documented in the medical record (range 0%-100%; higher scores indicate greater caregiver understanding of the hospital course).
Secondary outcomes
LOS
Length of stay
Readmission
7-day and 30-day readmission rates: readmissions within 7 or 30 days of the index hospitalization, when related to problems addressed during the initial hospitalization.
ED reutilization
7-day and 30-day ED re-utilization rates: return visits to the emergency department within 7 or 30 days for complaints related to the initial hospitalization.
Tokens
Token burden: the number of tokens used per AI-generated care summary.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.